Search

Your search keyword '"El Chenawi, Farha"' showing total 9 results
Start Over Author "El Chenawi, Farha"
9 results on '"El Chenawi, Farha"'

3. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon

Author

Fopa, Diderot, Candotti, Daniel, Tagny, Claude T., Doux, Camille, Mbanya, Dora, Murphy, Edward L., Kenawy, Hany I., El Chenawi, Farha, Laperche, Syria, Hôpital Central de Yaoundé, Institut National de la Transfusion Sanguine [Paris] (INTS), University of Yaoundé [Cameroun], University of California [San Francisco] (UC San Francisco), University of California (UC), Mansoura University [Egypt], and Candotti, Daniel

Subjects
[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology, occult hepatitis B infection, Yaoundé-Cameroon, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, virus diseases, blood donors, Original Article, digestive system diseases
Abstract

International audience; BackgroundIn Cameroon, the prevention of hepatitis B virus (HBV) transmission by blood transfusion is still only based on hepatitis B surface antigen (HBsAg) screening. However, occult HBV infection (OBI) characterised by the absence of detectable HBsAg and low level of viral DNA remains a potential threat for blood safety. The prevalence of OBI was investigated in blood donors from Yaoundé to provide evidence-based recommendations to improve HBV blood safety.Material and methodsBlood donations from August 1st, 2016 to March 31st, 2017 were routinely screened for HBV, human immunodeficiency virus (HIV), and hepatitis C virus (HCV) infections (Murex HBsAg Version 3, Murex HIV Ag/Ab Combination, and Murex HCV Ag/Ab Combination [DiaSorin]). Additional HBV investigations were performed, including hepatitis B core antibody ([HBc] Monolisa Anti-HBc PLUS; BIO-RAD) and HBV DNA tested in minipools of two samples using the quantitative Cobas Taqman HBV assay (Roche; LoQ: 6 IU/mL) and HBV DNA genotyping by sequencing.ResultsOf 1,162 donations analysed, 91 (7.8%) were reactive for HBsAg. All of them were also anti-HBc positive. Among the 1,071 HBsAg negative samples, 522 (48.7%) were reactive for anti-HBc. Six (0.56% of all donations) samples fulfilled the consensus definition of OBI and showed low HBV DNA loads (all

Published
2019
Full Text
View/download PDF

4. Distribution of the CCR5 gene 32 base pair deletion and SDF1–3'A variant in healthy individuals from different populations

Author

Magierowska, Magda, Lepage, V., Boubnova, Ludmila, Carcassi, Carlo, de Juan, Dolores, Djoulah, Sami, El Chenawi, Farha, Grunnet, Niels, Hallé, Liliane, Ivanova, Rayna, Jungerman, Malgorzata, Naumova, Elisabeth, Petrany, Gyözö, Sonnerborg, Anders, Stavropoulos, Catherine, Thorsby, Eric, Vu-Trieu, An, Debré, Patrice, Theodorou, Ioannis, and Charron, Dominique

Published
1998
Full Text
View/download PDF

9. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon.

Author

Fopa D, Candotti D, Tagny CT, Doux C, Mbanya D, Murphy EL, Kenawy HI, El Chenawi F, and Laperche S

Subjects
Adult, Cameroon epidemiology, Female, Hepatitis B epidemiology, Hepatitis C blood, Hepatitis C epidemiology, Humans, Male, Polymerase Chain Reaction, Blood Donors, Blood Safety, DNA, Viral blood, Donor Selection, Hepatitis B blood, Hepatitis B Surface Antigens blood, Hepatitis B virus
Abstract

Background: In Cameroon, the prevention of hepatitis B virus (HBV) transmission by blood transfusion is still only based on hepatitis B surface antigen (HBsAg) screening. However, occult HBV infection (OBI) characterised by the absence of detectable HBsAg and low level of viral DNA remains a potential threat for blood safety. The prevalence of OBI was investigated in blood donors from Yaoundé to provide evidence-based recommendations to improve HBV blood safety., Material and Methods: Blood donations from August 1 st , 2016 to March 31 st , 2017 were routinely screened for HBV, human immunodeficiency virus (HIV), and hepatitis C virus (HCV) infections (Murex HBsAg Version 3, Murex HIV Ag/Ab Combination, and Murex HCV Ag/Ab Combination [DiaSorin]). Additional HBV investigations were performed, including hepatitis B core antibody ([HBc] Monolisa Anti-HBc PLUS; BIO-RAD) and HBV DNA tested in minipools of two samples using the quantitative Cobas Taqman HBV assay (Roche; LoQ: 6 IU/mL) and HBV DNA genotyping by sequencing., Results: Of 1,162 donations analysed, 91 (7.8%) were reactive for HBsAg. All of them were also anti-HBc positive. Among the 1,071 HBsAg negative samples, 522 (48.7%) were reactive for anti-HBc. Six (0.56% of all donations) samples fulfilled the consensus definition of OBI and showed low HBV DNA loads (all <6 IU/mL). Following nested polymerase chain reaction amplifications, HBV DNA sequences were obtained for 4 of these samples (1 nearly whole genome [3123 nt], 2 Pre-S/S regions [1,356 nt], and 1 S region [445 nt]). Phylogenetic analysis identified genotype E in all samples., Discussion: Around 1 in 100 Cameroonian blood donors screened who resulted HBsAg negative and anti-HBc positive carried occult HBV infection. HBsAg alone for screening prospective donors is not sufficient to eliminate the risk of HBV transfusion transmission in Cameroon, and because anti-HBc screening does not seem to be feasible without compromising blood supply, implementation of HBV nucleic acid testing could be considered when possible.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results